Bone mineral content in patients with congenital generalized lipodystrophy is unaffected by metreleptin replacement therapy (Q33999013)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Bone mineral content in patients with congenital generalized lipodystrophy is unaffected by metreleptin replacement therapy
scientific article

    Statements

    Bone mineral content in patients with congenital generalized lipodystrophy is unaffected by metreleptin replacement therapy (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit